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Abstract
A case of triphenyltin acetate (TPTA) poison-
ing is described. The patient, who had been
exposed mainly to cutaneous absorption,
showed acute stages of an urticarial eruption,
signs of hepatic injury, slight glucose
intolerance, and electroencephalographic
abnormalities. Concomitant with the highest
concentrations of tin in plasma and the peak of
tin excretion in urine, neutrophils did not show
the normal increase in actin polymerisation
after stimulation with a chemotactic peptide
(100 nM fMLP). The peak of urinary excretion
of tin occurred between the fifth and the sixth
day after poisoning; subsequently, the rate of
excretion became slow, suggesting biphasic
kinetics with the possiblity of a cumulative
trend.
Triphenyltin acetate (TPTA) belongs to the group of
organotin compounds used world wide as biocides.
In Italy 500 000 Kg of organotin compounds were
used in 1984.' Triphenyltin acetate is used as a
molluscicide, an antifouling agent, a fungicide, and a
rodent repellant.2 About 25 years ago, a mixture of
organotin compounds used for the treatment of boils,
osteomyelitis, anthrax, and acne poisoned at least 217
people, of whom 100 died.3 The most common
clinical picture was characterised by impairment of
the central nervous system (CNS) with interstitial
oedema of the white matter.3
Cases of intoxication due to occupational exposure
have also been published. The main route of absorp-
tion seems to be the respiratory tract. Some degree of
cutaneous absorption, however, cannot be
excluded."7 The most common clinical findings were
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headache, dizziness, photophobia, nausea, and
vomiting. Sometimes temporary loss of conscious-
ness, epileptic seizures, dermatitis, and asthaenia
were seen.4578 Laboratory findings included tran-
sitory hyperglycaemia, glycosuria, and an increase in
activity of liver transaminases (alanine aminotrans-
ferase (ALT) and aspartate aminotransferase (AST))
that sometimes persisted weeks after poisoning.5
Organotin compounds produce neurotoxicity and
immunotoxicity in rats.9 Trialkyltin compounds
inhibit oxidative phosphorylation in mitochondria in
vitro.'01' They also cause haemolysis of erythro-
cytes,"2 probably due to an interaction of erythrocyte
membrane components with alkyl radicals.'3 They
inhibit DNA synthesis and cAMP production in
isolated rat thymocytes,"4 and impair chemotaxis and
phagocytosis in rabbit neutrophils."'
Recently, an effect of organotin compounds on
polymorphonuclear leucocytes (PMN) was shown.
This consisted of a decrease in the amount of the
polymerised form of actin in human neutrophils,
with inhibition of the actin polymerisation normally
detectable on stimulation of the cells with a
chemotactic peptide (fMLP).'6
Case history
The patient, a man aged 36, was accidentally exposed
to an unknown amount of 18-95% formulation
TPTA (Brestan).
He was handling a package of the compound
without gloves and spilt the pesticide powder on the
exposed cutaneous area of his arms. He washed
immediately but about 12 hours later experienced
bilateral plantar pain and, after around 24 hours,
severe genital oedema. Some hours later an eryth-
ematous eruption appeared on his trunk (see fig 1). In
the past he had had similar accidents with TPTA
without reporting any adverse effects on his health.
Two days after the accident, the patient had general
malaise, dizziness, nausea, and abdominal pain for
which he was admitted to hospital.
On admission, temperature, pulse rate, and blood
pressure were normal; physical examination showed
slight genital oedema, urticarial eruptions on his
trunk, and pronounced hepatomegaly (lower liver
margin about 5 cm below the costal margin). Blood
glucose concentration was 113 mg/100 ml (normal
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Figure 1 Urticarial eruption on the patient exposed to
triphenyltin acetate.
value 60-110), y-glutamyl transpeptidase (y-GT)
68 IU/1, and bilirubin 1 52 mg/100 ml (normal value
0 36). Other routine laboratory findings were nor-
mal. A glucose tolerance test on the fifth day showed
impairment of glucose metabolism and slight
glycosuria.
The day after admission to hospital, activity of
serum transaminases was high (AST 76 IU/1, ALT
198 IU/1). Some indices of inflammation were also
raised (mucoproteins 165 mg/dl (normal value
55-140); C-reactive protein 67 pg/ml (normal value
0-5)).
The rise in activity of transaminase persisted, with
a progressive decrease for 18 days. When the patient
was discharged 21 days after the accident, ALT
(41 IU/1) and y-GT (75 IU/1) activities were still
slightly high.
Despite steroid treatment 8, 10, 12, and 14 days
after the poisoning, the patient showed recrudes-
cences of urticarial eruption on his trunk and arms.
Allergological investigation, performed by patch
tests with entire Brestan and with each single com-
ponent in its formulation, did not produce any
positive results.
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Ten days after the accident, an electroenceph-
alogram (EEG) showed alterations consisting of
generalised paroxysmal abnormalities in a picture of
bradyrhythmia. On the 11th day serum IgE was
raised (543 IU/ml (normal value < 200)). Twelve
days after poisoning a hepatic echotomography
showed a generalised enlargement of the liver.
Examination of a liver needle biopsy specimen taken
three days later showed slight and non-specific
inflammatory abnormalities. A focal mononuclear
lobular infiltration was found accompanied by slight
steatosis that could be attributed to a daily alcohol
intake of around 200 g.
The patient was discharged 21 days after the
poisoning, apparently completely recovered. Some-
what high ALT and y-GT activities with slight
hepatomegaly persisted. During the next five
months, the patient suffered from periodic urticaria
on his trunk and arms. The cutaneous eruptions were
attenuated by antihistamines, and reappeared when
treatment was stopped. About six weeks after the
poisoning he developed angioedema which persisted
for several days. Four months after the poisoning, the
EEG showed slight anomalies during hyperpnea.
Laboratory investigations
The intake of TPTA was estimated by determining
the concentration of tin in blood and urine. Ten
samples of blood and eight samples of urine were
taken between the second and the 19th day after
poisoning. One sample of blood and two samples of
urine (morning and evening) were taken five months
later. Analyses were performed by atomic absorption
spectroscopy."7 On the fourth, eighth, and 16th day
circulating neutrophils were separated by the method
ofBoyum,'8 and stimulated with 100nM fMLP. The
increase in actin polymerisation was then determined
using the NBD phallacidin staining method.'9 This
test was repeated five months later. The peak of
urinary tin excretion occurred between the fifth and
the sixth day (96 pig/l, fig 2) and decreased to a
concentration of about 30 ig/l by the eighth day.
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Figure 2 Time sequence ofPMN actin polymerisation and
tin excretion in patient exposed to triphenyltin acetate.
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Subsequently, the rate of excretion decreased; one
month after the poisoning a urinary concentration of
28 ,g/l was found. This was still higher than the tin
concentration in the urine sample taken two days
after the poisoning (18 yg/l).
Reference values are not available but in our
experience values range from six to 30 pg/l in non-
exposed subjects. Tin disappeared rapidly from the
plasma, most being lost between the second and
fourth day concomitant with the increase in urinary
excretion. A second, small peak in tin concentration
in blood was found on the sixth day (fig 2).
On the fourth day, the PMNs did not show any
increase in actin polymerisation in comparison with
PMNs of healthy human subjects (p < 0-01); on the
eighth day, the PMNs had recovered somewhat,
although their activity was still lower than that of
healthy human subjects (p < 0-01). Activity of
PMNs was normal by 16 days after the accident
(fig 2).
Discussion
The patient showed usual signs of organotin poison-
ing-namely, dizziness, nausea, possible impairment
of the central nervous system, and liver damage.
Our clinical findings seem to confirm results
obtained in animals indicating that TPTA is less
neurotoxic than other organotin compounds as the
patient showed only electroencephalographic
anomalies with no clinical evidence of impairment of
the CNS. The bilateral plantar pain suffered 12
hours after the poisoning could be a sign of slight
impairment of the peripheral nervous system.
Other organotin compounds-for example,
tributyl and dibutylin-cause cutaneous erythema
due to an irritative effect8; the patient under study did
not show any such effect. The severe genital oedema
and the urticarial eruption with an increase in
circulating IgE, which persisted in spite of steroid
treatment and without exposure to TPTA, have not
previously been described as associated with
organotin poisoning. On the basis of the history of
the patient we believe we can attribute these findings
to TPTA poisoning. The lack of evidence of cutan-
eous sensitisation to the components of the product
may be due to the presence of unknown metabolites
acting as antigens; the persistence of urticarial erup-
tions could be interpreted as a chronic urticaria
caused by the unknown antigen(s) and not depending
on a mechanism belonging to the first group of Gell
and Coomb's classification.
The mechanism by which the liver is damaged by
organotin compounds is still not clear; some authors
have postulated an impairment of the hepatic trans-
port mechanism or the conjugation of bilirubin with
glutathione, or both.5 In our case the concentration of
serum bile acid, measured to evaluate possible
impairment of the hepatic transport mechanism,"0
remained normal.
It is interesting that PMN activity seems to be
impaired by TPTA. At the time of the peak of
urinary tin excretion, the patient's PMNs did not
show the normal actin polymerisation in response to
a stimulus. They had partly recovered by eight days
and had returned to normal 16 days after poisoning.
These data seem to confirm the findings ofa decrease
in the amount of the polymerised form of actin (F-
actin), the main component of microfilaments, found
in laboratory studies.'6
The determination of tin in blood and urine
showed an abnormally high concentration of tin. The
rates of urinary excretion and disappearance from
blood indicate biphasic kinetics, and suggest the
possibility of a cumulative action. No data on the
metabolic fate ofTPTA in man are available and the
toxicological significance of these findings is
still unclear. Our findings imply that TPTA can
penetrate the unbroken skin; a degree of respiratory
absorption, however, cannot be excluded.
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